Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy 07/10/2019 OBSERVATIONAL not-comparable 2,649.75 0 FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery 07/11/2019 INTERVENTIONAL not-comparable 2,648.75 0 Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes. 07/15/2019 INTERVENTIONAL not-comparable 2,644.75 0 Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients 07/17/2019 OBSERVATIONAL not-comparable 2,642.75 0 NeoVax With Nivolumab in Patients With Ovarian Cancer 07/18/2019 INTERVENTIONAL not-comparable 2,641.75 0 Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery 07/18/2019 INTERVENTIONAL not-comparable 2,641.75 0 Deceased Uterine Transplant in Absolute Uterine Infertility (AUIF) 07/19/2019 INTERVENTIONAL not-comparable 2,640.75 0 Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients 07/24/2019 INTERVENTIONAL not-comparable 2,635.75 0 Transcriptional and Epigenetic Program of PCOS Women 07/26/2019 OBSERVATIONAL not-comparable 2,633.75 0 Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer 07/29/2019 INTERVENTIONAL not-comparable 2,630.75 0 Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. 07/31/2019 INTERVENTIONAL not-comparable 2,628.75 0 A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer 07/31/2019 INTERVENTIONAL not-comparable 2,628.75 0 A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome 08/01/2019 INTERVENTIONAL not-comparable 2,627.75 0 Laser Vaginal Treatment for GSM 08/02/2019 INTERVENTIONAL not-comparable 2,626.75 0 Bioenergetic Effects of Aging and Menopause (BEAM) 08/02/2019 INTERVENTIONAL not-comparable 2,626.75 0 LASER and Radiofrequency and Genitourinary Syndrome of Menopause 08/05/2019 INTERVENTIONAL not-comparable 2,623.75 0 Vaginal Microbiota Transplant 08/06/2019 INTERVENTIONAL not-comparable 2,622.75 0 Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA 08/07/2019 INTERVENTIONAL not-comparable 2,621.75 0 Perioperative Mindfulness Proposal 08/08/2019 INTERVENTIONAL not-comparable 2,620.75 0 IDENTIFY Study: Natural History of Maternal Neoplasia 08/08/2019 OBSERVATIONAL not-comparable 2,620.75 0 Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer 08/08/2019 INTERVENTIONAL not-comparable 2,620.75 0 Autonomic Determinants of POTS - Pilot1 08/08/2019 INTERVENTIONAL not-comparable 2,620.75 0 Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study 08/12/2019 INTERVENTIONAL not-comparable 2,616.75 0 Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC 08/13/2019 INTERVENTIONAL not-comparable 2,615.75 0 ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer 08/14/2019 INTERVENTIONAL not-comparable 2,614.75 0 Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN 08/15/2019 OBSERVATIONAL not-comparable 2,613.75 0 Westlake Precision Birth Cohort 08/16/2019 INTERVENTIONAL not-comparable 2,612.75 0 Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer. 08/20/2019 INTERVENTIONAL not-comparable 2,608.75 0 Phase III Trial of Stage I Ovarian Cancer After Surgery 08/21/2019 INTERVENTIONAL not-comparable 2,607.75 0 GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET 08/22/2019 INTERVENTIONAL not-comparable 2,606.75 0 The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer 08/22/2019 INTERVENTIONAL not-comparable 2,606.75 0 ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss 08/22/2019 INTERVENTIONAL not-comparable 2,606.75 0 Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer 08/22/2019 OBSERVATIONAL not-comparable 2,606.75 0 RANKL Inhibition and Mammographic Breast Density 08/26/2019 INTERVENTIONAL not-comparable 2,602.75 0 Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients 08/28/2019 OBSERVATIONAL not-comparable 2,600.75 0 Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer 08/28/2019 INTERVENTIONAL not-comparable 2,600.75 0 Implementation of Prevention and Intervention of Maternal Perinatal Depression to Strengthen Maternal and Child Health 08/28/2019 INTERVENTIONAL not-comparable 2,600.75 0 RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer 08/28/2019 INTERVENTIONAL not-comparable 2,600.75 0 Sentinel Node Biopsy Vs Observation After Axillary PET 08/28/2019 INTERVENTIONAL not-comparable 2,600.75 0 Sentinel Node Biopsy in Endometrial Cancer 08/29/2019 INTERVENTIONAL not-comparable 2,599.75 0 LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2) 09/09/2019 INTERVENTIONAL not-comparable 2,588.75 0 Uptake of Genetic Counseling Among African American Women 09/09/2019 INTERVENTIONAL not-comparable 2,588.75 0 Induction of Gut Permeability by an Oral Vaccine 09/10/2019 INTERVENTIONAL not-comparable 2,587.75 0 Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer 09/10/2019 INTERVENTIONAL not-comparable 2,587.75 0 Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer 09/10/2019 INTERVENTIONAL not-comparable 2,587.75 0 Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia 09/10/2019 INTERVENTIONAL not-comparable 2,587.75 0 Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania 09/11/2019 INTERVENTIONAL not-comparable 2,586.75 0 The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study 09/12/2019 OBSERVATIONAL not-comparable 2,585.75 0 Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors 09/13/2019 INTERVENTIONAL not-comparable 2,584.75 0 Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer 09/16/2019 INTERVENTIONAL not-comparable 2,581.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology